U.S. Liquid Biopsy Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2032

U.S. Liquid Biopsy Market: By Technology (Multi Gene Parallel Analysis (NGS) and Single Gene Analysis (PCR Microarrays)), Product (Blood Sample Based and Others); Biomarker (Circulating Nucleic Acids, CTC, Exosomes/Microvesicles, Circulating Proteins)— Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2024–2032

U.S. liquid biopsy market was valued at US$ 3,786.2 million in 2023 and is projected to surpass a market valuation of US$ 12,004.9 million by 2032 at a CAGR of 13.68% during the forecast period 2024–2032. Read More

We Are Trusted By These Great Companies!

• Published On: 07-May-2024  |  Format:  |  Report ID: AA0823577